KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Astrana Health (ASTH) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Astrana Health (ASTH) over the last 16 years, with Q3 2025 value amounting to $445000.0.

  • Astrana Health's Other Non Operating Income fell 8335.2% to $445000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.1 million, marking a year-over-year decrease of 14920.04%. This contributed to the annual value of $4.9 million for FY2024, which is 2035.62% down from last year.
  • As of Q3 2025, Astrana Health's Other Non Operating Income stood at $445000.0, which was down 8335.2% from $1.1 million recorded in Q2 2025.
  • Astrana Health's Other Non Operating Income's 5-year high stood at $10.3 million during Q4 2021, with a 5-year trough of -$15.9 million in Q2 2021.
  • Its 5-year average for Other Non Operating Income is $405315.8, with a median of $1.2 million in 2023.
  • Over the last 5 years, Astrana Health's Other Non Operating Income had its largest YoY gain of 246384.44% in 2021, and its largest YoY loss of 133892.36% in 2021.
  • Over the past 5 years, Astrana Health's Other Non Operating Income (Quarter) stood at $10.3 million in 2021, then crashed by 84.36% to $1.6 million in 2022, then rose by 14.85% to $1.9 million in 2023, then crashed by 80.98% to $353000.0 in 2024, then rose by 26.06% to $445000.0 in 2025.
  • Its Other Non Operating Income was $445000.0 in Q3 2025, compared to $1.1 million in Q2 2025 and -$5.1 million in Q1 2025.